Lydia Hickman is a graduate student in the Cook Lab at the University of Birmingham in the United Kingdom. In her Ph.D. work, she explores the fundamental biological mechanisms underlying motor function and social cognition in the context of autism and Parkinson’s disease. Lydia co-founded the U21 Autism Research Network, an international collaboration among six research groups aiming to improve diversity and inclusion in autism research.
Lydia Hickman
Graduate student
University of Birmingham in the United Kingdom
From this contributor
Ways to make autism research more diverse and inclusive
Scientists must focus on the importance of representative study samples and of engaging with diverse autism community members.
Ways to make autism research more diverse and inclusive
By
Lydia Hickman
14 June 2022 | 6 min read
Explore more from The Transmitter
To understand decision-making, we need to truly challenge lab animals
Complex, multidimensional tasks that unfold over time could reveal how different brain areas work together to support decisions.
To understand decision-making, we need to truly challenge lab animals
Complex, multidimensional tasks that unfold over time could reveal how different brain areas work together to support decisions.
By
Chand Chandrasekaran
20 April 2026 | 6 min read
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
By
Angie Voyles Askham
17 April 2026 | 8 min read
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
By
Charles Q. Choi
16 April 2026 | 4 min read